Antitumor necrosis factor-alpha (TNF-α) agents are widely used for effective treatment of autoimmune rheumatic and dermatological diseases such as rheumatoid arthritis (RA), ankylosing spondylitis (SA), psoriasis (Ps), or psoriatic arthritis (PsA). The gene discussed is TNF; the disease is rheumatoid arthritis.